Maglangit, Alma May G.

HRN: 21-89-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500mg
BID
S/P NSD With Repair
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines